Phenome-India National Biobank (CSIR-IGIB)

National population biobank (2025) — Longitudinal population data study.

Country: India

Research Institute National population biobank (2025)

Coverage

	CN	EU	IN	US
diagnostics-medtech	✓	✓	✓	✓

Regulatorsfdaemanmpa

Verifiable facts

Fact	Value	Source
Affiliation	Council of Scientific and Industrial Research (CSIR), India; Institute of Genomics and Integrative Biology (CSIR-IGIB)	doi.org · phenomeindia.igib.res.in · biobanking.com · medrxiv.org
Research focus	Cardio-metabolic diseases (including diabetes, heart disease, liver disease), longitudinal health trajectory monitoring, genomics, and precision medicine	doi.org · phenomeindia.igib.res.in · galaxyclasses.co.in
Facility	Phenome India National Biobank located at CSIR-IGIB, New Delhi	doi.org · biobanking.com · galaxyclasses.co.in
Grant	HCP47	cbri.res.in · doi.org · scienceindiamag.in · medrxiv.org
Publications	Research protocol and disease burden studies, including MASLD and liver fibrosis research	doi.org · medrxiv.org · researchgate.net
Principal staff	Souvik Maiti, Shantanu Sengupta, Viren Sardana, Kumardeep Chaudhary	scienceindiamag.in · biospectrumindia.com · medrxiv.org
Headcount	10,000 individuals (employees, retirees, and spouses)	csirnews.niscpr.res.in · doi.org · novojuris.com · galaxyclasses.co.in · medrxiv.org

Independent sources: biobanking.com · biospectrumindia.com · cbri.res.in · csirnews.niscpr.res.in · doi.org · galaxyclasses.co.in · medrxiv.org · novojuris.com · researchgate.net · scienceindiamag.in

Technologies

Name	Cluster	Risk
Biobanks of human & population samples	diagnostics-medtech	Low	→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.